Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

Código QR

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

Ying Cao,1,&ast; Yibei Dai,1,&ast; Lingyu Zhang,1 Danhua Wang,1 Wen Hu,2 Qiao Yu,3 Xuchu Wang,1 Pan Yu,1 Weiwei Liu,1 Ying Ping,1 Tao Sun,1 Yiwen Sang,1 Zhenping Liu,4 Yan Chen,3 Zhihua Tao1 1Department of Laboratory Medicine, Zhejiang University School of Medicine Second Affiliated Hospital...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cao Y, Dai Y, Zhang L, Wang D, Hu W, Yu Q, Wang X, Yu P, Liu W, Ping Y, Sun T, Sang Y, Liu Z, Chen Y, Tao Z
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	inflammatory bowel disease fecal biomarkers oncostatin m calprotectin diagnosis activity infliximab response Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/66e06f62a534404c901716fefdb9cf78
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016)

WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
por: Henning P, et al.
Publicado: (2021)

Fecal microbiota transplant – a new frontier in inflammatory bowel disease
por: Sunkara T, et al.
Publicado: (2018)

Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease
por: Niina A, et al.
Publicado: (2019)

Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study
por: Magdalena Koszewicz, et al.
Publicado: (2021)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
por: Sara Salvador-Martín, et al.
Publicado: (2021)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad M, et al.
Publicado: (2020)

Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease
por: Nathaniel D. Chu, et al.
Publicado: (2021)

Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment
por: Yaryna Boyko, et al.
Publicado: (2020)

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
por: Youlian Zhou, et al.
Publicado: (2018)

Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
por: Velikova Tsvetelina, et al.
Publicado: (2018)

Management of fecal incontinence - focus on a vaginal insert for bowel control
por: Sokol ER
Publicado: (2016)

Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis
por: Emma Altobelli, et al.
Publicado: (2021)

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Xu X, et al.
Publicado: (2021)

Systematic Metabolic Profiling of Mice with Dextran Sulfate Sodium-Induced Colitis
por: Xie D, et al.
Publicado: (2021)

Application of Artificial Intelligence Modeling Technology Based on Multi-Omics in Noninvasive Diagnosis of Inflammatory Bowel Disease
por: Huang Q, et al.
Publicado: (2021)

Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease
por: Wang L, et al.
Publicado: (2021)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Xiufang Cui, et al.
Publicado: (2021)

Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)
por: Cury DB, et al.
Publicado: (2019)

Seminars in inflammatory bowel disease
Publicado: (2001)

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
por: Rawla P, et al.
Publicado: (2018)

Diagnostic and Prognostic Value of Immune/Inflammation Biomarkers for Venous Thromboembolism: Is It Reliable for Clinical Practice?
por: Xue J, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Gianluca Ianiro, et al.
Publicado: (2021)

Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease
por: Al-Meghaiseeb ES, et al.
Publicado: (2016)

Dynamics of the Level of Myeloperoxidase and Serum Calprotectin in Local Cold Injury
por: M. I. Mikhailichenko, et al.
Publicado: (2020)

Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
por: Matthew K. Doherty, et al.
Publicado: (2018)

The role of inflammation in irritable bowel syndrome (IBS)
por: Ng QX, et al.
Publicado: (2018)

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model
por: David Ternant, et al.
Publicado: (2021)

Effects of crowding and sex on fecal cortisol levels of captive forest musk deer
por: He,Lan, et al.
Publicado: (2014)

Selenium-Containing Amino Acids Protect Dextran Sulfate Sodium-Induced Colitis via Ameliorating Oxidative Stress and Intestinal Inflammation
por: Shi C, et al.
Publicado: (2021)

The Flavonoid Kurarinone Regulates Macrophage Functions via Aryl Hydrocarbon Receptor and Alleviates Intestinal Inflammation in Irritable Bowel Syndrome
por: Xu X, et al.
Publicado: (2021)

Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management
por: Igor G. Bakulin, et al.
Publicado: (2021)

Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: A case report
por: Sagar Walinjkar, et al.
Publicado: (2021)

Integrated Gene Expression Profiling Analysis Reveals Probable Molecular Mechanism and Candidate Biomarker in Anti-TNFα Non-Response IBD Patients
por: Liu Y, et al.
Publicado: (2020)

Editorial: Game Changers in Inflammatory Bowel Diseases
por: Anita Bálint, et al.
Publicado: (2021)

Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease
por: Sznurkowska K, et al.
Publicado: (2020)

Biomarcadores en enfermedad inflamatoria intestinal: ¿sabe cómo utilizarlos?
por: Pérez de Arce,Edith, et al.
Publicado: (2020)

Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer
por: Yuji Fujita, et al.
Publicado: (2021)

Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome
por: Chao G, et al.
Publicado: (2021)

Gut Microbiota Contributes to Host Defense Against Klebsiella pneumoniae-Induced Liver Abscess
por: Zheng Y, et al.
Publicado: (2021)